- Home
- VUZI vs LXRX Comparison
VUZI vs LXRX Comparison
Compare VUZI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VUZI
- LXRX
- Stock Information
- Founded
- VUZI 1997
- LXRX 1995
- Country
- VUZI United States
- LXRX United States
- Employees
- VUZI N/A
- LXRX N/A
- Industry
- VUZI Industrial Machinery/Components
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- VUZI Technology
- LXRX Health Care
- Exchange
- VUZI Nasdaq
- LXRX Nasdaq
- Market Cap
- VUZI 122.9M
- LXRX 124.4M
- IPO Year
- VUZI N/A
- LXRX 2000
- Fundamental
- Price
- VUZI $2.60
- LXRX $0.63
- Analyst Decision
- VUZI Strong Buy
- LXRX Buy
- Analyst Count
- VUZI 1
- LXRX 4
- Target Price
- VUZI $2.00
- LXRX $3.67
- AVG Volume (30 Days)
- VUZI 1.4M
- LXRX 5.6M
- Earning Date
- VUZI 05-12-2025
- LXRX 05-13-2025
- Dividend Yield
- VUZI N/A
- LXRX N/A
- EPS Growth
- VUZI N/A
- LXRX N/A
- EPS
- VUZI N/A
- LXRX N/A
- Revenue
- VUZI $5,331,630.00
- LXRX $31,081,000.00
- Revenue This Year
- VUZI $43.59
- LXRX N/A
- Revenue Next Year
- VUZI $55.00
- LXRX $84.78
- P/E Ratio
- VUZI N/A
- LXRX N/A
- Revenue Growth
- VUZI N/A
- LXRX 2481.48
- 52 Week Low
- VUZI $0.83
- LXRX $0.28
- 52 Week High
- VUZI $5.79
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- VUZI 69.19
- LXRX 50.73
- Support Level
- VUZI $1.71
- LXRX $0.63
- Resistance Level
- VUZI $2.20
- LXRX $0.72
- Average True Range (ATR)
- VUZI 0.18
- LXRX 0.07
- MACD
- VUZI 0.08
- LXRX -0.01
- Stochastic Oscillator
- VUZI 94.15
- LXRX 0.00
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacturing, marketing, and selling of Smart Glasses and Augmented Reality (AR) technologies and products for the enterprise, medical, defense, and consumer markets. Its products include head-mounted (or HMDs or heads-up displays or HUDs) smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays, and augmented reality, as well as OEM waveguide optical components and display engines. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, Netherlands, and other countries.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.